Loading data
GHRSNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 38.77 m USD | 35.02 m USD | 29.82 m USD | 20.48 m USD | 8.55 m USD |
| Selling, general and administrative expense | 21.95 m USD | 15.3 m USD | 11.4 m USD | 10.07 m USD | 6.55 m USD |
| Operating profit | -60.72 m USD | -50.31 m USD | -41.22 m USD | -30.55 m USD | -15.1 m USD |
| Interest expense | 463 k USD | 717 k USD | 63 k USD | 0 USD | 9 k USD |
| Profit before tax | -48.26 m USD | -38.96 m USD | -35.59 m USD | -22.46 m USD | -9.2 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | -48.26 m USD | -38.96 m USD | -35.59 m USD | -22.46 m USD | -9.2 m USD |
| Net income attributable to owners of the parent | -48.26 m USD | -38.96 m USD | -35.59 m USD | -22.46 m USD | -9.2 m USD |
| Basic earnings per share | -0.79 USD/share | -0.75 USD/share | -0.68 USD/share | -0.43 USD/share | -0.21 USD/share |
| Diluted earnings per share | -0.79 USD/share | -0.75 USD/share | -0.68 USD/share | -0.43 USD/share | -0.21 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.